BioWorld MedTech

July 7, 2015

Hansen gets bump to start ARTISAN: Hansen Medical completes enrollment in initial cohort of ARTISAN clinical trial

Coming off a 5.07% bump in its shares last week, intravascular robotics specialist Hansen Medical (NASDAQ: HNSN) (Mountain View, Calif.) said it has completed enrollment in the initial evaluable cohort of its ARTISAN clinical trial. Read More

Two patents invalidated: Fed Circuit: 'Experimental' manufacturing dooms patents

Latin America: British device aker looks to ride LatAm growth

Inside the Beltway: Economic impact report makes implicit argument for repeal of device tax

Report from Europe: EU Council readies CE mark reform for 'trialogue' negotiation

Daily M&A: Vygon Group buys Preouse to upgrade vascular access

Financings: Lantheus closes initial public offering,brings in nearly $66.7 million

World in Review: Lensar moves into Indian market, establishing Sharp Sight Centers

Products

Court Report: Enzo Biochem reaches $7.1M settlement with Luminex

People in Places

Briefly noted

MDD's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 22, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 22, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...